RT Journal Article
SR Electronic
T1 Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004780
DO 10.1136/jitc-2022-004780
VO 11
IS 3
A1 Atkins, Michael B
A1 Jegede, Opeyemi A
A1 Haas, Naomi B
A1 McDermott, David F
A1 Bilen, Mehmet A
A1 Stein, Mark
A1 Sosman, Jeffrey A
A1 Alter, Robert
A1 Plimack, Elizabeth R
A1 Ornstein, Moshe C
A1 Hurwitz, Michael
A1 Peace, David J
A1 Signoretti, Sabina
A1 Denize, Thomas
A1 Cimadamore, Alessia
A1 Wu, Catherine J
A1 Braun, David
A1 Einstein, David
A1 Catalano, Paul J
A1 Hammers, Hans
YR 2023
UL http://jitc.bmj.com/content/11/3/e004780.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.